1. Home
  2. GFI vs INSM Comparison

GFI vs INSM Comparison

Compare GFI & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFI
  • INSM
  • Stock Information
  • Founded
  • GFI 1887
  • INSM 1988
  • Country
  • GFI South Africa
  • INSM United States
  • Employees
  • GFI N/A
  • INSM N/A
  • Industry
  • GFI Precious Metals
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFI Basic Materials
  • INSM Health Care
  • Exchange
  • GFI Nasdaq
  • INSM Nasdaq
  • Market Cap
  • GFI 20.5B
  • INSM 19.1B
  • IPO Year
  • GFI 2007
  • INSM 2000
  • Fundamental
  • Price
  • GFI $24.08
  • INSM $99.11
  • Analyst Decision
  • GFI Hold
  • INSM Strong Buy
  • Analyst Count
  • GFI 3
  • INSM 17
  • Target Price
  • GFI $20.93
  • INSM $108.07
  • AVG Volume (30 Days)
  • GFI 2.8M
  • INSM 5.0M
  • Earning Date
  • GFI 08-22-2025
  • INSM 08-07-2025
  • Dividend Yield
  • GFI 1.84%
  • INSM N/A
  • EPS Growth
  • GFI 78.24
  • INSM N/A
  • EPS
  • GFI 1.38
  • INSM N/A
  • Revenue
  • GFI $5,201,600,000.00
  • INSM $381,030,000.00
  • Revenue This Year
  • GFI $39.63
  • INSM $28.03
  • Revenue Next Year
  • GFI $13.08
  • INSM $120.54
  • P/E Ratio
  • GFI $17.36
  • INSM N/A
  • Revenue Growth
  • GFI 15.57
  • INSM 20.77
  • 52 Week Low
  • GFI $12.98
  • INSM $60.40
  • 52 Week High
  • GFI $26.36
  • INSM $106.83
  • Technical
  • Relative Strength Index (RSI)
  • GFI 51.49
  • INSM 62.52
  • Support Level
  • GFI $23.24
  • INSM $95.27
  • Resistance Level
  • GFI $24.83
  • INSM $98.53
  • Average True Range (ATR)
  • GFI 0.70
  • INSM 2.77
  • MACD
  • GFI -0.07
  • INSM -1.45
  • Stochastic Oscillator
  • GFI 65.37
  • INSM 34.45

About GFI Gold Fields Limited

Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: